P139: Development of treatment model for HIV/HCV co‐infected OST patients as the basis for scaling up access to HCV treatment for key populations in Ukraine

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2893|22|S2|89-89

ISSN： 1352-0504

Source： JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol.22, Iss.S2, 2015-06, pp. : 89-89

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

P089: Scaling up access to HCV treatment in Ukraine

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. S2, 2015-06 ,pp. : 65-65

John Wiley & Sons Inc

Access to resources Recommend Favorite

Acute and chronic immune biomarker changes during interferon/ribavirin treatment in HIV/HCV co‐infected patients

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. 1, 2015-01 ,pp. : 25-36

John Wiley & Sons Inc

Access to resources Recommend Favorite

Occult hepatitis B in HIV-HCV coinfected patients

By Piroth Lionel   Lafon Marie-Edith   Binquet Christine   Bertillon Pascale   Gervais Anne   Lootvoet Enguerrand   Lang Jean-Marie   Jaureguiberry Jean   Chene Genevieve   Leport Catherine  

Scandinavian Journal of Infectious Diseases, Vol. 40, Iss. 10, 2008-01 ,pp. : 835-839

Informa Healthcare

Access to resources Recommend Favorite

FREE PAPER HCV TREATMENT O‐24: The German multicenter cohort on direct antiviral agents in HCV‐ and HIV/HCV‐infected patients (GECODAA)

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. S2, 2015-06 ,pp. : 14-15

John Wiley & Sons Inc

Access to resources Recommend Favorite

Rates and predictors of response to anti‐viral treatment for hepatitis C virus in HIV/HCV co‐infection in a nationwide study of 619 patients

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 38, Iss. 11-12, 2013-12 ,pp. : 1373-1384

John Wiley & Sons Inc

Access to resources Recommend Favorite